{
    "code": "02024738",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024738",
    "time": "2022-08-06 07:44:46",
    "許可證字號": "衛署藥輸字第024738號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/11\/02",
    "發證日期": "96\/11\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202473800",
    "中文品名": "癌克平注射液",
    "英文品名": "Intaxel Injection",
    "適應症": "晚期卵巢癌、液下淋巴轉移之乳癌，作為接續含杜薩魯比辛 (DOXORUBICIN) 在內之輔助化學療法、已使用合併療法 (除非有禁忌，至少應包括使用ANTHRACYCLINE抗癌藥) 失敗的轉移乳癌、非小細胞肺癌、愛滋病相關卡波西氏肉瘤之第二線療法；與CISPLATIN併用，作為晚期卵巢癌之第一線療法。與GEMCITABINE併用，可使用於曾經使用過ANTHRACYCLINE之局部復發且無法手術切除或轉移性之乳癌病患、與HERCEPTIN併用時，用於治療未接受過化學治療之轉移性且乳癌過度表現HER-2之病人。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 5、16.7、43.4、50毫升小瓶裝 25毫升小瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PACLITAXEL",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0368000  FRESENIUS KABI ONCOLOGY LIMITED",
            "製造廠廠址": "VILLAGE-KISHANPURA, P.O. GURU MAJRA, TEHSIL-NALAGARH, DISTT. SOLAN, (H.P.)-174101, INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000100",
            "成分名稱": "PACLITAXEL",
            "含量描述": "",
            "含量": "6.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "全頁相片-104-12-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024738&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "癌克平注射液仿單 FKT-024738-0918-107-10-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024738&Seq=018&Type=9"
        },
        {
            "title": "Intaxel- 100 mg_Label&Carton-107-10-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024738&Seq=018&Type=8"
        }
    ]
}